Composition and method for treating glaucoma

An antiglaucoma composition containing as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride of the general formula: where R1=R2=R3=R4=H=R5=R6=R7=CH3O The composition is used as an ophthalmic solution in a method for treatin...

Full description

Saved in:
Bibliographic Details
Main Authors NISSIMOV; JOSSIF N, IVANOV; CHAVDAR B, BEROVA; NIKOLINA D, JELYAZKOV; DELTCHO G, TODOROVA; MARIA G, ZIKOLOVA; TATYANA S, POPOVA; DIANA D, OVCHAROV; RADI G, SLAVOVA; EMILIYA D, MONDESCHKA; DIANA M, UZUNOV; PETKO D, RAKOVSKA; ROSITZA S, MARINOVA; VIOLA M, MARKOV; MARKO T, GENTCHEVA; DOBRINKA G
Format Patent
LanguageEnglish
Published 08.05.1990
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:An antiglaucoma composition containing as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride of the general formula: where R1=R2=R3=R4=H=R5=R6=R7=CH3O The composition is used as an ophthalmic solution in a method for treating glaucoma by administering a therapeutic dose of 2 to 3 drops two to four times daily to a host such as a warm-blooded animal having glaucoma.
Bibliography:Application Number: US19880163595